Jeffrey Huber Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Investments
  • 14

  • Portfolio
  • 8

  • Exits
  • 5

Exits

Jeffrey Huber General Information

Description

Mr. Jeffrey Huber is a Co-Founder and serves as General Partner at Triatomic Capital. He also serves as a Board Member at Summit Therapeutics. He is an Angel Investor. He co-founded and served as Vice Chairman at GRAIL. He serves as a Board Member at Electronic Arts. He serves as Chairman at Mammoth Biosciences. He serves as a Board Member at Manifold Bio, Upstart. He served as a Board Member at Ancestry. He serves as Chairman at Genalyte. He serves as a Board Member at Zapata Computing. He serves as a Board Member at Openwater. He is an Advisor of StrongBlock. Before Grail, he worked at the intersection of life sciences and computer science at Google. Previously at Google, he led development for Google Ads, Google Apps, and Google Maps. He holds a bachelor's degree in Computer Engineering from the University of Illinois and a master's degree from Harvard University. He is a Board member & Member of the Audit Committee of Electronic Arts (EA) Board Member of The Exploratorium and a former board member of Illumina. He has also served as an Advisor at Blue Horizon Equity. He serves as a Board Member at d-Matrix.

Business Details

Year Founded
1968
Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • 2950 South Delaware Street
  • Suite 410
  • San Mateo, CA 94403
  • United States
+1 (833)

Jeffrey Huber Investments (14)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Synapticure 01-Feb-2022 Seed Round Clinics/Outpatient Services Generating Revenue
Superhuman 27-Jun-2019 Business/Productivity Software Generating Revenue
Openwater 10-Dec-2018 Diagnostic Equipment Startup
Honor 20-Sep-2018 Information Services (B2C) Generating Revenue
Atomwise 02-Jul-2018 Drug Discovery Pre-Clinical Trials
Kiavi 12-Mar-2018 Specialized Finance Generating Revenue
Vir 06-Jan-2017 Drug Discovery Generating Revenue/Not Profitable
Razorpay 26-Oct-2015 Financial Software Generating Revenue
Atomwise 05-May-2015 Seed Round Drug Discovery Pre-Clinical Trials
Poshmark 21-Apr-2015 Later Stage VC Internet Retail Profitable

Jeffrey Huber Exits (5)

Company Name Exit Date Exit Type Exit Size
Caribou Biosciences 23-Jul-2021 IPO
Zymergen 22-Apr-2021
Poshmark 14-Jan-2021
UXPin 09-Jun-2020 Buyout/LBO
Vir 11-Oct-2019 IPO

Jeffrey Huber Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Jeffrey Huber Co-Investors (17)

Name With Exits Lead Partner Series Industry
GV 1 Series chart Industry bar
Joe Kraus Series chart Industry bar
Martin Ventures Series chart Industry bar
Ronald Conway Series chart Industry bar
Sandro Salsano Series chart Industry bar

Jeffrey Huber FAQs

  • Who is Jeffrey Huber?

    Jeffrey Huber is an angel Investor who has made 14 investments.

  • What kind of investor is Jeffrey Huber?

    Jeffrey Huber is an angel investor.

  • What does Jeffrey Huber do?

    As an angel investor, Jeffrey Huber invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Jeffrey Huber hold?

    Jeffrey Huber holds 7 board seats including Summit Therapeutics, d-Matrix, Upstart Holdings, Openwater, and Electronic Arts.

  • What has Jeffrey Huber invested in?

    Jeffrey Huber has made numerous investments in companies like Synapticure, Superhuman, and Openwater within the Clinics/Outpatient Services, Business/Productivity Software, and Diagnostic Equipment industries.

  • What has Jeffrey Huber invested in recently?

    Jeffrey Huber's latest investment was on 01-Feb-2022 in Synapticure, a company within the Clinics/Outpatient Services industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »